Lyell Immunopharma Inc

LYEL NASDAQ Santé & Biotech États-Unis US55083R1041
17.11 $
1.60 %

Entreprise de biotechnologie concentrée sur le développement de thérapies cellulaires pour le traitement du cancer.

Performance & Momentum

6 Months 22.58 %
1 Year 112.81 %
3 Years 69.00 %
5 Years 94.72 %

Similar stocks to Lyell Immunopharma Inc

Anantys Community

Be the first to share your analysis on Lyell Immunopharma Inc.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases